443 related articles for article (PubMed ID: 25088200)
1. The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cells.
Gurgis FM; Yeung YT; Tang MX; Heng B; Buckland M; Ammit AJ; Haapasalo J; Haapasalo H; Guillemin GJ; Grewal T; Munoz L
Oncogene; 2015 May; 34(22):2934-42. PubMed ID: 25088200
[TBL] [Abstract][Full Text] [Related]
2. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
3. IL-1β-induced and p38
Kulawik A; Engesser R; Ehlting C; Raue A; Albrecht U; Hahn B; Lehmann WD; Gaestel M; Klingmüller U; Häussinger D; Timmer J; Bode JG
J Biol Chem; 2017 Apr; 292(15):6291-6302. PubMed ID: 28223354
[TBL] [Abstract][Full Text] [Related]
4. The MK2/HuR signaling pathway regulates TNF-α-induced ICAM-1 expression by promoting the stabilization of ICAM-1 mRNA.
Wu T; Shi JX; Geng S; Zhou W; Shi Y; Su X
BMC Pulm Med; 2016 May; 16(1):84. PubMed ID: 27215284
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor-induced interleukin-6 expression via human antigen R.
Xu J; Su X; Shi JX; Sun H; Wu T; Shi Y
Chin Med J (Engl); 2013 Nov; 126(22):4322-6. PubMed ID: 24238522
[TBL] [Abstract][Full Text] [Related]
6. Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation.
Radtke S; Wüller S; Yang XP; Lippok BE; Mütze B; Mais C; de Leur HS; Bode JG; Gaestel M; Heinrich PC; Behrmann I; Schaper F; Hermanns HM
J Cell Sci; 2010 Mar; 123(Pt 6):947-59. PubMed ID: 20200229
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide destabilizes cyclooxygenase-2 mRNA by inhibiting p38 mitogen-activated protein kinase and cytoplasmic shuttling of HuR.
Jin SH; Kim TI; Yang KM; Kim WH
Eur J Pharmacol; 2007 Mar; 558(1-3):14-20. PubMed ID: 17208222
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer.
Morgan D; Berggren KL; Spiess CD; Smith HM; Tejwani A; Weir SJ; Lominska CE; Thomas SM; Gan GN
Mol Carcinog; 2022 Feb; 61(2):173-199. PubMed ID: 34559922
[TBL] [Abstract][Full Text] [Related]
9. The RNA-binding protein HuR stabilizes cytosolic phospholipase A2α mRNA under interleukin-1β treatment in non-small cell lung cancer A549 Cells.
Liao WL; Wang WC; Chang WC; Tseng JT
J Biol Chem; 2011 Oct; 286(41):35499-35508. PubMed ID: 21862584
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic Ras modulates p38 MAPK-mediated inflammatory cytokine production in glioblastoma cells.
Munoz L; Yeung YT; Grewal T
Cancer Biol Ther; 2016 Apr; 17(4):355-63. PubMed ID: 26794430
[TBL] [Abstract][Full Text] [Related]
11. p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells.
Yeung YT; Bryce NS; Adams S; Braidy N; Konayagi M; McDonald KL; Teo C; Guillemin GJ; Grewal T; Munoz L
J Neurooncol; 2012 Aug; 109(1):35-44. PubMed ID: 22528800
[TBL] [Abstract][Full Text] [Related]
12. Post-transcriptional regulation of TNF-induced expression of ICAM-1 and IL-8 in human lung microvascular endothelial cells: an obligatory role for the p38 MAPK-MK2 pathway dissociated with HSP27.
Su X; Ao L; Zou N; Song Y; Yang X; Cai GY; Fullerton DA; Meng X
Biochim Biophys Acta; 2008 Sep; 1783(9):1623-31. PubMed ID: 18486623
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
14. Cigarette smoke and its component acrolein augment IL-8/CXCL8 mRNA stability via p38 MAPK/MK2 signaling in human pulmonary cells.
Moretto N; Bertolini S; Iadicicco C; Marchini G; Kaur M; Volpi G; Patacchini R; Singh D; Facchinetti F
Am J Physiol Lung Cell Mol Physiol; 2012 Nov; 303(10):L929-38. PubMed ID: 22983351
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells.
Jagielska J; Kapopara PR; Salguero G; Scherr M; Schütt H; Grote K; Schieffer B; Bavendiek U
Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1280-8. PubMed ID: 22345171
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
[TBL] [Abstract][Full Text] [Related]
17. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Postoperative Ileus by Lentivirus-Mediated HuR RNA Interference via the p38/MK2 Signaling Pathway.
Xiong YD; Rong LX; Pan C
J Gastrointest Surg; 2017 Feb; 21(2):389-397. PubMed ID: 27796636
[TBL] [Abstract][Full Text] [Related]
19. The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation.
Tiedje C; Ronkina N; Tehrani M; Dhamija S; Laass K; Holtmann H; Kotlyarov A; Gaestel M
PLoS Genet; 2012 Sep; 8(9):e1002977. PubMed ID: 23028373
[TBL] [Abstract][Full Text] [Related]
20. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
